Xencor, Inc. (XNCR) is a publicly traded Healthcare sector company. As of May 21, 2026, XNCR trades at $11.33 with a market cap of $820.01M and a P/E ratio of -4.86. XNCR moved +8.79% today. Year to date, XNCR is -20.67%; over the trailing twelve months it is +39.07%. Its 52-week range spans $6.92 to $27.24. Analyst consensus is strong buy with an average price target of $26.00. Rallies surfaces XNCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes XNCR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $11.33 |
| Market Cap | $820.01M |
| P/E Ratio | -4.86 |
| EPS | $-2.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.24 |
| 52-Week Low | $6.92 |
| Volume | 447 |
| Avg Volume | 0 |
| Revenue (TTM) | $97.36M |
| Net Income | $-172.42M |
| Gross Margin | 0.00% |
12 analysts cover XNCR: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.00.